https://doctransparency.com/doctor/tx/plano/mark-allen-1528023397
Medicare Enrolled

Dr. Mark Allen, M.D.

Urology Physician · Plano, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5300 W PLANO PKWY, Plano, TX 75093
9726128037
In practice since 2006 (19 years)
NPI: 1528023397 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Allen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Allen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Allen

Dr. Mark Allen is an urology physician in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Allen performed 8,243 Medicare services across 2,296 unique beneficiaries.

Between the years covered by Open Payments, Dr. Allen received a total of $7,147 from 68 pharmaceutical and/or device companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Allen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 12% volume in TX$ $7,147 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,243
Medicare services
Top 12% in TX for urology physician
2,296
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~434 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
BCG treatment for bladder cancer4,150$2$4
Urinalysis, manual1,224$3$20
Office visit, established patient (20-29 min)1,052$61$105
Infectious disease DNA/RNA test312$34$80
Leuprolide acetate (for depot suspension), 7.5 mg295$135$882
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional158$17$80
Diagnostic exam of bladder and urethra using an endoscope125$176$425
Yeast/candida DNA test120$34$80
Bladder ultrasound after voiding116$8$100
New patient office visit (30-44 min)93$76$180
X-ray of abdomen, 1 view86$20$75
Instillation of anti-cancer drug into bladder79$64$350
Office visit, established patient (30-39 min)69$89$150
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle50$26$57
New patient office visit (45-59 min)41$113$245
Simple insertion of temporary bladder tube28$45$150
Biopsy of prostate gland26$95$450
Ultrasound scan of pelvic region through rectum26$25$275
Ultrasonic guidance for needle placement26$23$270
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique24$34$80
Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique24$34$80
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique24$34$80
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique24$34$80
Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique18$34$80
Detection test by nucleic acid for multiple organisms, amplified probe(s) technique18$69$150
Shock wave crushing of kidney stones12$412$2,600
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope12$551$2,300
Creation of sling around urethra in female to control leakage11$569$2,700
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,147
Total received (2018-2024)
Avg $1,021/year across 7 years
Top 27% in TX for urology physician
68
Companies
317
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,056 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$91 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,210
2023
$1,051
2022
$1,398
2021
$800
2020
$414
2019
$708
2018
$1,567

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,075
Boston Scientific Corporation
$531
Intuitive Surgical, Inc.
$511
ABBVIE INC.
$404
Agiliti Surgical, Inc.
$376
PFIZER INC.
$363
AbbVie Inc.
$334
Sumitomo Pharma America, Inc.
$279
AbbVie, Inc.
$186
C. R. Bard, Inc. & Subsidiaries
$178
Myovant Sciences Inc.
$154
Verity Pharmaceuticals Inc.
$151
Caldera Medical, Inc
$145
Accord Healthcare, Inc.
$132
Axonics, Inc.
$128
BOSTON SCIENTIFIC CORPORATION
$123
Endo Pharmaceuticals Inc.
$123
Merck Sharp & Dohme Corporation
$113
BIOTISSUE HOLDINGS, INC.
$104
Medtronic, Inc.
$104
Antares Pharma, Inc.
$100
Dendreon Pharmaceuticals LLC
$97
PROCEPT BioRobotics Corporation
$84
Blue Earth Diagnostics Limited
$83
UROVANT SCIENCES INC
$73
BioTissue Holdings, Inc.
$70
Merck Sharp & Dohme LLC
$65
COLOPLAST CORP
$64
Allergan, Inc.
$63
Rochester Medical Corporation
$56
Olympus America Inc.
$49
Innovation Technologies Inc
$48
Endo USA, Inc.
$47
ConvaTec Inc.
$35
Palette Life Sciences, Inc.
$35
Avadel Specialty Pharmaceuticals, LLC
$35
Coloplast Corp
$33
Baxter Healthcare
$31
Laborie Medical Technologies Corp.
$28
Egalet US Inc
$27
Janssen Biotech, Inc.
$27
Progenics Pharmaceuticals, Inc.
$24
Allergan Inc.
$24
Ferring Pharmaceuticals Inc.
$24
TISSUETECH, INC.
$23
Cook Medical LLC
$22
Telix Pharmaceuticals
$21
Amgen Inc.
$20
STERIS CORPORATION
$20
Integra LifeSciences Corporation
$20
BAXTER HEALTHCARE
$20
Travere Therapeutics, Inc.
$19
ACCORD HEALTHCARE, INC.
$19
PROGENICS PHARMACEUTICALS, INC.
$18
UroGen Pharma, Inc.
$18
Janssen Scientific Affairs, LLC
$17
Bayer HealthCare Pharmaceuticals Inc.
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
UROGEN PHARMA, INC.
$16
Novartis Pharmaceuticals Corporation
$16
Horizon Therapeutics plc
$16
KARL STORZ Endoscopy-America
$15
Hollister Incorporated
$15
Profound Medical Corp.
$14
Levita Magnetics International Corp
$14
Avadel Pharmaceuticals (USA), Inc.
$13
Augmenix, Inc.
$13
Mission Pharmacal Company
$12
Top 3 companies account for 29.6% of total payments
Associated products mentioned in payments ›
8.5 FR. X 700MM · ADSTILADRIN · ADVANCE · ADVANTAGE FIT · AMS · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Altis · Androgel · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CMOS VIDEO URETEROSCOPE · CODMAN CERTAS · Da Vinci Surgical System · Desara · Erleada · FLEXIVA · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · GREENLIGHT · General - Kidney Stone Disease · GentleCath · ILLUCCIX · INTERSTIM · IRRISEPT · ImaJin · Infyna Chic · JANUVIA · JELMYTO · KEYTRUDA · Karbinal ER · Koelis Trinity Fusion Biopsy System · LUPRON DEPOT · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Magnetic Surgery · Myrbetriq · NATPARA (PARATHYROID HORMONE) · NEOX · Noctiva · Nubeqa · ORGOVYX · OTREXUP · Olympus Cysto-Resection · Olympus Digital Flexible Ureteroscopes · Olympus Ureteroscopes · Otrexup · PLUVICTO · PNEUMOVAX 23 · PROVENGE · PYLARIFY · Prolia · RAYOS · RESONANCE · REZUM · SIGNIA · SPACEOAR · SPRIX · Sonablate · Sonablate HIFU · SpaceOAR · TISSEEL · TOVIAZ · Thiola · Titan · Trelstar · UPHOLD LITE · Uretero1 · Urocit-K · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $87 per 100 Medicare services performed
Looking for a urology physician in Plano?
Compare urology physicians in the Plano area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
132
Per 100K population
11.8
County median income
$117,588
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL PLANO
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Allen is a clinical cardiology specialist, with above-average Medicare volume (top 12% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Allen experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Allen performed 4,150 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Allen receive payments from pharmaceutical companies?
Yes. Dr. Allen received a total of $7,147 from 68 companies across 317 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Allen's costs compare to other urology physicians in Plano?
Dr. Allen's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Allen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →